[go: up one dir, main page]

CN205163373U - Meibomian gland pipe mediation probe - Google Patents

Meibomian gland pipe mediation probe Download PDF

Info

Publication number
CN205163373U
CN205163373U CN201520934608.1U CN201520934608U CN205163373U CN 205163373 U CN205163373 U CN 205163373U CN 201520934608 U CN201520934608 U CN 201520934608U CN 205163373 U CN205163373 U CN 205163373U
Authority
CN
China
Prior art keywords
stainless steel
dredging
meibomian gland
conduit
piston
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201520934608.1U
Other languages
Chinese (zh)
Inventor
王庆强
贾新国
丛松霞
王桂梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201520934608.1U priority Critical patent/CN205163373U/en
Application granted granted Critical
Publication of CN205163373U publication Critical patent/CN205163373U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

The utility model belongs to the field of medical devices, a medical instrument for dredging the meibomian gland pipe is related to. It is the injection vessel shape, comprises with the portion of managing the work head. The work head forms with stainless steel sellves 2 by nonrust steel wire 1, manage and form by sleeve 4, piston 3 and push -and -pull rod 5. A termination stainless steel sellves 2 of sleeve 4, the other end is equipped with the opening of the push -and -pull rod 5 that is used for pegging graft, the front end of push -and -pull rod be connected with piston 3, nonrust steel wire 1 insert in the stainless steel sellves 2 to in being fixed in piston 3, the suit is in sleeve 4. Suitably adjusting the length that nonrust steel wire stretches out during the use, slowly inserting obstructed meibomian gland pipe, the twist grip gently while advancing reaches the mediation purpose, pushes the meibomian gland pipe after the mediation, discharges secretion for the glandular tube resumes unobstructed. The utility model discloses the ability is deep enough dredges to the gland is inside, effectively removes the blockage of meibomian gland pipe, quick effective, workably safe, economical and practical.

Description

Tarsal glands conduit dredging probe
Technical field
This utility model belongs to medical instruments field, relates to a kind of medical apparatus and instruments for the treatment of ocular disease, specifically relates to a kind of medical apparatus and instruments of dredging tarsal glands conduit.
Background technology
Meibomian gland dysfunction (MeibomianGlandDysfunction, MGD) be a kind of chronic, diffusivity tarsus dysfunction, usually with tarsal glands eventually the obstruction of last conduit and/or Meibomian gland secretion material or amount change into feature, often cause tear film exception, irritated eyes, eye table inflammation and damage can be caused, wherein modal pathological changes is rear portion blepharitis and lipid shortage property xerophthalmia (LipidTearDeficiency, LTD).Although these situations can not threat to life, the life quality of ophthalmic uncomfortable to patient continued causes significant impact.Meibomian gland dysfunction (MGD) is a kind of worldwide disease, and according to the literature, the sickness rate of MGD is at 3.5%-70%, this disease is especially high at the sickness rate of asian population, Bangkok reports that the sickness rate of a specific crowd is 46.2%, and Japan is 61.9%, and Beijing is then up to 69.3%.Along with the raising of people's quality of life, meibomian gland dysfunction (MGD) more and more receives the concern of scholars.At present, meibomian gland dysfunction (MGD) has been one of eye surface diseases study hotspot in the world.
Normal meibomian gland secretions is transparent, and the patient of meibomian gland dysfunction (MGD), massage eyelid often can extrude a large amount of muddiness, cystose, the meibomian gland secretions of graininess or toothpaste-like.Have research once to attempt to discharge abnormal secretion thing by simple eyelid massage, result shows, normal Ovum Gallus domesticus album sample secretions can be discharged smoothly, and graininess secretions is difficult to discharge, and toothpaste-like secretions is more difficult discharge then.
Research finds, the key problem of meibomian gland dysfunction (MGD) is the obstruction of tarsal glands conduit.Therefore, the treatment key of meibomian gland dysfunction (MGD) effectively dredges tarsal glands conduit, removes the obstruction of conduit, and then improve Meibomian gland secretion function, improves therapeutic effect.Clinical practice is badly in need of a kind of safe and effective, economical and practical tarsal glands dredging probe, can be deep into body of gland inside, and effectively the tarsal glands conduit of dredging obstruction, makes it recover unobstructed.
The list of references relevant with this utility model has:
Wang Qingqiang, Zhang Jing, Jia Xinguo etc. the application of microprobe dredging art in meibomian gland dysfunction patient treatment. Shandong medicine, 2014,54 (25): 86-89.
Wang Qingqiang, Jia Xinguo, Zhang Wenbo etc. the application of microprobe dredging art in meibomian gland dysfunction treatment. international ophthalmology magazine, 2014,14 (7): 1269-1271.
Summary of the invention
The purpose of this utility model is the defect and the deficiency that overcome existing treatment technology, provides a kind of medical apparatus and instruments being used for the treatment of ocular disease, specifically relates to a kind of medical apparatus and instruments of dredging tarsal glands conduit.
The purpose of this utility model is achieved in that it is syringe shape, be made up of working head and the portion of managing, described working head is made up of stainless steel silk 1 and rustless steel sleeve pipe 2, the portion that manages is made up of sleeve 4, piston 3 and push-pull bar 5, one termination stainless steel sleeve pipe 2 of described sleeve 4, the other end is provided with the opening for grafting push-pull bar 5, the front end of described push-pull bar 5 is connected with piston 3, described stainless steel silk 1 inserts in rustless steel sleeve pipe 2, and be fixed in piston 3, be sleeved in sleeve 4.
In this utility model, described stainless steel silk 1 diameter is 0.1mm.
In this utility model, described rustless steel sleeve pipe 2 length is 5mm, and internal diameter is 0.15mm.
In this utility model, described stainless steel silk 1 stretches out in the adjustable in length of rustless steel sleeve pipe 2, greatest length is 5mm, according to the anatomical physiology characteristic of tarsal glands conduit, extension elongation can be adjusted to 5mm during dredging upper eyelid glandular tube, extension elongation can be adjusted to 2.5mm during dredging lower eyelid glandular tube, use that rear cleaning is complete can be adjusted to 0 by extension elongation, so as to sterilize, safe storage.
In this utility model, described minister's degree of managing is 30mm.
Using method: 0.5% oxybuprocaine eye drop instillation is suffered from eye conjunctival sac, anaesthetize successfully, advise patient to be placed in by lower jaw part on slit lamp Lower jaw support, suitably regulate stainless steel silk to stretch out in the length of rustless steel sleeve pipe, according to tarsal glands conduit direction of travel, slowly the tarsal glands conduit of obstruction, expansion is inserted, advance limit, limit rotating probe handle gently, reaches dredging object, extruding tarsal glands conduit after dredging, secretions is discharged, makes glandular tube recover unobstructed.
Tarsal glands conduit dredging probe of the present utility model uses through a large amount of patients clinical, and result display is effective, safe and feasible fast, economical and practical.
The advantage of Tarsal gland obstruction treatment instrument of the present utility model: compared with prior art, this utility model can be deep into body of gland inside and dredge, abundant efficient solution is except the obstruction of tarsal glands conduit, the therapeutic effect of further raising meibomian gland dysfunction (MGD), effectively for patient shortens treatment time, save medical expense.
For the ease of understanding, this utility model is further illustrated below in conjunction with accompanying drawing, it needs to be noted, instantiation and accompanying drawing are only to illustrate, obvious those of ordinary skill in the art can according to illustrating herein, in scope of the present utility model, make various correction and change to the present invention, these are revised and change and also include in scope of the present utility model.
Accompanying drawing explanation
Fig. 1 is the overall appearance view of this utility model tarsal glands conduit dredging probe.
Fig. 2, Fig. 3 are the exploded views of Fig. 1.
Detailed description of the invention
It is syringe shape, be made up of working head and the portion of managing, described working head is made up of stainless steel silk 1 and rustless steel sleeve pipe 2, the portion that manages is made up of sleeve 4, piston 3 and push-pull bar 5, a termination stainless steel sleeve pipe 2 of described sleeve 4, and the other end is provided with the opening for grafting push-pull bar 5, the front end of described push-pull bar 5 is connected with piston 3, described stainless steel silk 1 inserts in rustless steel sleeve pipe 2, and is fixed in piston 3, is sleeved in sleeve 4.
0.5% oxybuprocaine eye drop instillation is suffered from eye conjunctival sac, anaesthetize successfully, advise patient to be placed in by lower jaw part on slit lamp Lower jaw support, suitably regulate stainless steel silk to stretch out in the length of rustless steel sleeve pipe, according to tarsal glands conduit direction of travel, slowly the tarsal glands conduit of obstruction, expansion is inserted, advance limit, limit rotating probe handle gently, reaches dredging object, extruding tarsal glands conduit after dredging, secretions is discharged, makes glandular tube recover unobstructed.
Stainless steel silk described in the utility model stretches out in the adjustable in length of rustless steel sleeve pipe, greatest length is 5mm, according to the anatomical physiology characteristic of tarsal glands conduit, extension elongation can be adjusted to 5mm during dredging upper eyelid glandular tube, extension elongation can be adjusted to 2.5mm during dredging lower eyelid glandular tube, use that rear cleaning is complete can be adjusted to 0 by extension elongation, so as to sterilize, safe storage.

Claims (5)

1. a tarsal glands conduit dredging probe, it is characterized in that: it is syringe shape, be made up of working head and the portion of managing, described working head is made up of stainless steel silk (1) and rustless steel sleeve pipe (2), the portion that manages is by sleeve (4), piston (3) and push-pull bar (5) composition, one termination stainless steel sleeve pipe (2) of described sleeve (4), the other end is provided with the opening for grafting push-pull bar (5), the front end of described push-pull bar (5) is connected with piston (3), described stainless steel silk (1) inserts in rustless steel sleeve pipe (2), and be fixed in piston (3), be sleeved in sleeve (4).
2., by tarsal glands conduit dredging probe according to claim 1, it is characterized in that, described stainless steel silk (1) diameter is 0.1mm.
3., by tarsal glands conduit dredging probe according to claim 1, it is characterized in that, described rustless steel sleeve pipe (2) length is 5mm, and internal diameter is 0.15mm.
4. by tarsal glands conduit dredging probe according to claim 1, it is characterized in that, described stainless steel silk (1) stretches out in the adjustable in length of rustless steel sleeve pipe (2), greatest length is 5mm, according to the anatomical physiology characteristic of tarsal glands conduit, during dredging upper eyelid glandular tube, extension elongation 5mm can be adjusted to, during dredging lower eyelid glandular tube, extension elongation 2.5mm can be adjusted to, use that rear cleaning is complete can be adjusted to 0 by extension elongation, so as to sterilize, safe storage.
5., by tarsal glands conduit dredging probe according to claim 1, it is characterized in that, described minister's degree of managing is 30mm.
CN201520934608.1U 2015-11-13 2015-11-13 Meibomian gland pipe mediation probe Expired - Fee Related CN205163373U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201520934608.1U CN205163373U (en) 2015-11-13 2015-11-13 Meibomian gland pipe mediation probe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201520934608.1U CN205163373U (en) 2015-11-13 2015-11-13 Meibomian gland pipe mediation probe

Publications (1)

Publication Number Publication Date
CN205163373U true CN205163373U (en) 2016-04-20

Family

ID=55727419

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201520934608.1U Expired - Fee Related CN205163373U (en) 2015-11-13 2015-11-13 Meibomian gland pipe mediation probe

Country Status (1)

Country Link
CN (1) CN205163373U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116687664A (en) * 2023-08-03 2023-09-05 北京同仁医学科技有限责任公司 Meibomian gland probe

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116687664A (en) * 2023-08-03 2023-09-05 北京同仁医学科技有限责任公司 Meibomian gland probe
CN116687664B (en) * 2023-08-03 2023-12-19 北京同仁医学科技有限责任公司 A meibomian gland probe needle

Similar Documents

Publication Publication Date Title
RU2017129247A (en) METHODS AND COMPOSITIONS FOR TREATING A DRY EYE DISEASE AND OTHER EYE DISEASES
Baliga et al. Orbital myiasis: a case report
CN205163373U (en) Meibomian gland pipe mediation probe
Fairburn et al. A cyst of Rathke's cleft
CN209108394U (en) A kind of gynemetrics's clinic injecting type feeding device
CN106821431A (en) A kind of medical eye speculum
CN205832133U (en) Meibomian gland massaging device
CN207708079U (en) Lacrimal embolism injector
Chumbley Canaliculitis caused by Enterobacter cloacae: report of a case.
CN103211677B (en) Retina extractor
CN108852614A (en) Lacrimal embolism injector
CN203315172U (en) Lacrimal drainage tube
RU220287U1 (en) Surgical instrument for clearing obstructed meibomian gland ducts
RU119999U1 (en) DACRIOSTOMA DILATOR FOR MICROENDOSCOPIC ENDONASAL DACRYOCISTORINOSTOMY
RU53896U1 (en) MARKER FOR ANTIGLAUCOMATIC OPERATIONS
CN205494001U (en) A scope equipment that is used for cerebral hemorrhage scope hematoma to clear away operation
Wang et al. Meta analysis about the efficacy and safety of anti-ocular hypertension eye drops without benzalkonium chloride
CN203886000U (en) Drug delivery device for ear cleaning
CN205041605U (en) Meibomian gland extrusion tweezers
CN214858193U (en) Lacrimal passage obstruction dredging operation treatment device
CN219049441U (en) Eye flusher
RU226157U1 (en) Cannula for irrigating the ear canal
RU2547960C1 (en) Method of treating eye surface in dry eye syndrome
CN211797663U (en) Novel ophthalmology nursing is washd device
CN221533861U (en) Skin focus scraping device

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160420

Termination date: 20171113

CF01 Termination of patent right due to non-payment of annual fee